These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21183736)
1. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Valenti L; Dongiovanni P; Motta BM; Swinkels DW; Bonara P; Rametta R; Burdick L; Frugoni C; Fracanzani AL; Fargion S Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):683-90. PubMed ID: 21183736 [TBL] [Abstract][Full Text] [Related]
2. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616 [TBL] [Abstract][Full Text] [Related]
3. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis. Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321 [TBL] [Abstract][Full Text] [Related]
5. Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. Peters HP; Rumjon A; Bansal SS; Laarakkers CM; van den Brand JA; Sarafidis P; Musto R; Malyszko J; Swinkels DW; Wetzels JF; Macdougall IC Nephrol Dial Transplant; 2012 Oct; 27(10):3923-9. PubMed ID: 22815544 [TBL] [Abstract][Full Text] [Related]
6. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation. Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000 [TBL] [Abstract][Full Text] [Related]
7. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection. Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485 [TBL] [Abstract][Full Text] [Related]
8. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375 [TBL] [Abstract][Full Text] [Related]
9. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease. Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592 [TBL] [Abstract][Full Text] [Related]
10. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis. Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400 [TBL] [Abstract][Full Text] [Related]
11. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. Luque-Ramírez M; Álvarez-Blasco F; Alpañés M; Escobar-Morreale HF J Clin Endocrinol Metab; 2011 Mar; 96(3):846-52. PubMed ID: 21209031 [TBL] [Abstract][Full Text] [Related]
12. Iron metabolism in patients with anorexia nervosa: elevated serum hepcidin concentrations in the absence of inflammation. Papillard-Marechal S; Sznajder M; Hurtado-Nedelec M; Alibay Y; Martin-Schmitt C; Dehoux M; Westerman M; Beaumont C; Chevallier B; Puy H; Stheneur C Am J Clin Nutr; 2012 Mar; 95(3):548-54. PubMed ID: 22301927 [TBL] [Abstract][Full Text] [Related]
13. Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. Mitchell RM; Lee SY; Randazzo WT; Simmons Z; Connor JR J Neuroinflammation; 2009 Feb; 6():6. PubMed ID: 19228389 [TBL] [Abstract][Full Text] [Related]
14. Immunoassay for human serum hepcidin. Ganz T; Olbina G; Girelli D; Nemeth E; Westerman M Blood; 2008 Nov; 112(10):4292-7. PubMed ID: 18689548 [TBL] [Abstract][Full Text] [Related]
15. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome. Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790 [TBL] [Abstract][Full Text] [Related]
16. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Kroot JJ; Laarakkers CM; Geurts-Moespot AJ; Grebenchtchikov N; Pickkers P; van Ede AE; Peters HP; van Dongen-Lases E; Wetzels JF; Sweep FC; Tjalsma H; Swinkels DW Clin Chem; 2010 Oct; 56(10):1570-9. PubMed ID: 20739637 [TBL] [Abstract][Full Text] [Related]
17. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. Hohaus S; Massini G; Giachelia M; Vannata B; Bozzoli V; Cuccaro A; D'Alo' F; Larocca LM; Raymakers RA; Swinkels DW; Voso MT; Leone G J Clin Oncol; 2010 May; 28(15):2538-43. PubMed ID: 20406921 [TBL] [Abstract][Full Text] [Related]
18. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018 [TBL] [Abstract][Full Text] [Related]
19. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. Fujita N; Sugimoto R; Motonishi S; Tomosugi N; Tanaka H; Takeo M; Iwasa M; Kobayashi Y; Hayashi H; Kaito M; Takei Y J Hepatol; 2008 Nov; 49(5):702-10. PubMed ID: 18620776 [TBL] [Abstract][Full Text] [Related]
20. Regulation of iron metabolism by hepcidin. Nemeth E; Ganz T Annu Rev Nutr; 2006; 26():323-42. PubMed ID: 16848710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]